A PHASE-II TRIAL OF HIGH-DOSE ARA-C AND MITOXANTRONE IN ACUTE NONLYMPHOBLASTIC LEUKEMIA (ANLL)

被引：0
|
作者：
FUHR, HG
LINDEMANN, A
HERRMANN, F
HIDDEMANN, W
MERTELSMANN, R
机构：
[1] UNIV MAINZ,DEPT HEMATOL,D-6500 MAINZ,FED REP GER
[2] UNIV MUNSTER,D-4400 MUNSTER,FED REP GER
来源：
INVESTIGATIONAL NEW DRUGS | 1987年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF POOR RISK ACUTE-LEUKEMIA WITH SEQUENTIAL HIGH-DOSE ARA-C AND ASPARAGINASE
    CAPIZZI, RL
    POOLE, M
    COOPER, MR
    RICHARDS, F
    STUART, JJ
    JACKSON, DV
    WHITE, DR
    SPURR, CL
    HOPKINS, JO
    MUSS, HB
    RUDNICK, SA
    WELLS, R
    GABRIEL, D
    ROSS, D
    BLOOD, 1984, 63 (03) : 694 - 700
  • [32] SUBACUTE PULMONARY FAILURE COMPLICATING THERAPY WITH HIGH-DOSE ARA-C IN ACUTE-LEUKEMIA
    ANDERSSON, BS
    COGAN, BM
    KEATING, MJ
    ESTEY, EH
    MCCREDIE, KB
    FREIREICH, EJ
    CANCER, 1985, 56 (09) : 2181 - 2184
  • [33] TREATMENT OF REFRACTORY AND RECIDIVIST ACUTE MYELOID-LEUKEMIA WITH HIGH-DOSE ARA-C AND AMSACRINE
    KALHS, P
    KOS, M
    JAGER, U
    SCHWARZINGER, I
    BETTELHEIM, P
    PANZER, S
    HINTERBERGER, W
    NEUMANN, E
    LECHNER, K
    ONKOLOGIE, 1987, 10 (05): : 279 - 280
  • [34] VITAMIN-A AND OR HIGH-DOSE ARA-C IN THE MAINTENANCE OF REMISSION IN ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN
    LIE, SO
    SLORDAHL, SH
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1984, 33 (03): : 256 - 259
  • [35] A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia
    Fukushima, Toshihiro
    Urasaki, Yoshimasa
    Yamaguchi, Masaki
    Ueda, Mikio
    Morinaga, Koji
    Haba, Toshihiro
    Sugiyama, Toshiro
    Nakao, Shinji
    Origasa, Hideki
    Umehara, Hisanori
    Ueda, Takanori
    ANTICANCER RESEARCH, 2012, 32 (02) : 643 - 647
  • [36] HIGH-DOSE ARA-C RELATED LEUKOENCEPHALOPATHY
    HWANG, TL
    YUNG, WKA
    LEE, YY
    BORIT, A
    FIELDS, WS
    JOURNAL OF NEURO-ONCOLOGY, 1986, 3 (04) : 335 - 339
  • [37] INTERMEDIATE AND HIGH-DOSE ARA-C AND M-AMSA FOR REMISSION INDUCTION AND CONSOLIDATION TREATMENT OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA - AN EORTC LEUKEMIA COOPERATIVE GROUP PHASE-II STUDY
    WILLEMZE, R
    JAGER, U
    JEHN, U
    STRYCKMANS, P
    BURY, J
    SUCIU, S
    SOLBU, G
    ZITTOUN, R
    BURGHOUTS, J
    LOWENBERG, B
    ABELS, J
    CAUCHIE, C
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (11): : 1721 - 1725
  • [38] HIGH-DOSE ARA-C THERAPY - A REVIEW
    GASSMANN, W
    SCHMITZ, N
    LOFFLER, H
    ONKOLOGIE, 1985, 8 (01): : 8 - &
  • [39] ALTERATION OF THE PHARMACOKINETICS OF HIGH-DOSE ARA-C BY ITS METABOLITE, HIGH ARA-U IN PATIENTS WITH ACUTE-LEUKEMIA
    CAPIZZI, RL
    YANG, JL
    CHENG, E
    BJORNSSON, T
    SAHASRABUDHE, D
    TAN, RS
    CHENG, YC
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) : 763 - 771
  • [40] MITOXANTRONE AND ARA-C IN PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    PACIUCCI, PA
    DUTCHER, JP
    CUTTNER, J
    STRAUMAN, JJ
    WIERNIK, PH
    HOLLAND, JF
    LEUKEMIA, 1987, 1 (07) : 565 - 567
12345